Med-tech company PolarCool AB (publ.) has successfully renewed its partnership with the Football Association of Wales (FAW), the governing body for football in Wales. The FAW has utilized the PolarCap® System for the men's national team to treat players suffering from concussions since 2022.

The FAW has been using the PolarCap® System since the 2022 FIFA World Cup, and due to their positive experience, they have continued to provide the treatment to players since then. This extension of the agreement with the FAW aligns with a growing list of sports organizations committed to improving player safety and concussion management.

PolarCool CEO Erik Andersson comments:

-Extending the agreement with the FAW's so the organization can continue to provide PolarCap® has significant symbolic value. The extension is also an important step for PolarCool in our expanding influence within professional football. The FAW's dedication to player safety is aligned with our mission to make concussion management a priority across all levels of sports.

PolarCool's growing customer base now includes partnerships with national teams and elite clubs across multiple sports in numerous countries. The agreement with the Football Association of Wales is strategically important, even if the financial significance of individual agreements is limited.

For more information

Erik Andersson - CEO PolarCool AB (publ.) 
+46 - 73 860 57 00    
E-mail: erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.